SARS-CoV-2 Vaccination: What Can We Expect Now?
At the beginning of summer 2022, my colleagues and I wanted to share some thoughts about a vaccination success story [...]
Main Authors: | François Meurens, Fanny Renois, Alexis Bouin, Jianzhong Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/7/1093 |
Similar Items
-
SARS-CoV-2 vaccines: What we know, what we can do to improve them and what we could learn from other well-known viruses
by: Sirio Fiorino, et al.
Published: (2022-11-01) -
Genomic Diversity of SARS-CoV-2 in Algeria and North African Countries: What We Know So Far and What We Expect?
by: Taha Menasria, et al.
Published: (2022-02-01) -
SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now
by: Iro Boura, et al.
Published: (2023-09-01) -
Molecularly Imprinted Polymer-Based Sensors for SARS-CoV-2: Where Are We Now?
by: Aysu Yarman, et al.
Published: (2022-05-01) -
Cardiomyopathy Associated with Anti-SARS-CoV-2 Vaccination: What Do We Know?
by: Alfredo Parra-Lucares, et al.
Published: (2021-12-01)